Publications

Rx-360 Guidance and Best Practices for Raw Material Supply Chain Security for Cell and Gene Therapies

Rx-360 Responding to the Threat of Illicit Medicines: Methodologies for Monitoring, Investigation & Stakeholder Engagement

Rx-360 Understanding the Threat of Illicit Medicines: An Overview of Counterfeit, Tampered, Unapproved and Diverted Pharmaceuticals

Remote Auditing Technology Best Practices and Solutions

Remote Auditing – A Supplier Perspective

Rx-360 Technical Visit Guidelines for the Regulated Medical Product Industry Upstream Supply Chain

Rx-360 Supply Chain Security White Paper: Incident Management Version 2.0

Rx-360 Remote Audit Best Practice Guide

Rx-360 Supply Chain Security: Audits and Assessments of Third-Party Warehousing and Distribution Facilities Version 2.0

Rx-360 Technical Paper on Tamper-Evidence and First Opening Indication

Rx-360 Supply Chain Security: Prevention of Re-use of Genuine Packaging Components for Counterfeit Products

Rx-360 Supply Chain Security: A Comprehensive Supply Chain Security Management System Version 2.0

Managing Critical Vendors

Rx-360 Natural Disaster Contingency Planning

Transition of ISO 13485 2003 to 2016

Taking a Collaborative Approach to Secure Donated Medicines

Integrating a Third Party Audit Provider into an Existing Supplier Quality Management Process

Quality Elements for Suppliers of Products or Services to GMP Regulated – Spanish Version

Rx-360 Quality Elements for Suppliers of Products or Services to GMP Regulated Companies

Cargo Theft in the Pharmaceutical Industry – What Does it Really Cost?

Upstream Supply Chain Mapping

Upstream Supply Chain Security